BVF Inc’s Molecular Partners MOLN Stock Holding History

BVF Inc’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.15M	Hold	1,353,968	–	–	0.13%	40
2026 Q1	$5.36M	Hold	1,353,968	–	–	0.17%	39
2025 Q4	$5.82M	Hold	1,353,968	–	–	0.2%	35
2025 Q3	$5.02M	Hold	1,353,968	–	–	0.2%	39
2025 Q2	$5.19M	Hold	1,353,968	–	–	0.19%	37
2025 Q1	$5.51M	Hold	1,353,968	–	–	0.22%	39
2024 Q4	$6.46M	Buy	1,353,968 +910,747	+205%	+$5.01M	0.22%	43
2024 Q3	$2.14M	Hold	443,221	–	–	0.06%	47
2024 Q2	$3.17M	Hold	443,221	–	–	0.09%	47
2024 Q1	$1.72M	Hold	443,221	–	–	0.05%	57
2023 Q4	$1.76M	Hold	443,221	–	–	0.04%	66
2023 Q3	$1.77M	Hold	443,221	–	–	0.05%	65
2023 Q2	$2.71M	Hold	443,221	–	–	0.08%	62
2023 Q1	$2.66M	Hold	443,221	–	–	0.1%	62
2022 Q4	$2.87M	Hold	443,221	–	–	0.12%	65
2022 Q3	$2.97M	Hold	443,221	–	–	0.12%	64
2022 Q2	$2.98M	Hold	443,221	–	–	0.14%	65
2022 Q1	$8.98M	Hold	443,221	–	–	0.36%	59
2021 Q4	$8.55M	Buy	443,221 +24,213	+6%	+$407K	0.31%	57
2021 Q3	$8.27M	Buy	+419,008	New	+$8.24M	0.32%	59

Other funds holding MOLN

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BVF Inc's MOLN Position: Q2 2026 in Review

BVF Inc held its Molecular Partners (MOLN) position steady in Q2 2026 at 1,353,968 shares worth $5.15M. The position accounts for 0.13% of the portfolio, ranked #40.

BVF Inc first reported a position in MOLN in Q3 2021 and has held it in 20 quarters since. The position peaked at $8.98M in Q1 2022. 5 funds tracked by Wall St. Rank hold MOLN as of Q2 2026.

BVF Inc held 1,353,968 shares of Molecular Partners worth $5.15M as of Q2 2026.
BVF Inc left its Molecular Partners share count unchanged in Q2 2026.
Molecular Partners made up 0.13% of BVF Inc's portfolio in Q2 2026, its #40 holding.
BVF Inc first reported a position in Molecular Partners in Q3 2021 and has held it in 20 quarters since.
BVF Inc's Molecular Partners position peaked at $8.98M in Q1 2022.
5 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.